Related content

Gefitinib

By Culy C.R.   Faulds D.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2237-2248

Adis International

Access to resources Recommend Favorite

Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations

By Park In   Kim Jin   Jung Jae   Han Ji-Youn  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 791-799

Springer Publishing Company

Access to resources Recommend Favorite

An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model System

By  

Current Cancer Drug Targets, Vol. 15, Iss. 5, 2015-01 ,pp. : 423-434

Bentham Science Publishers

Access to resources Recommend Favorite

βIII-Tubulin: biomarker of taxane resistance or drug target?

By Karki Roshan   Mariani Marisa   Andreoli Mirko   He Shiquan   Scambia Giovanni   Shahabi Shohreh   Ferlini Cristiano  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. : 461-472

Informa Healthcare

Access to resources Recommend Favorite

Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway

By  

Current Cancer Drug Targets, Vol. 17, Iss. 4, 2017-04 ,pp. : 376-385

Bentham Science Publishers

Access to resources Recommend Favorite